AC0058TA

DRUG2 trials

Sponsors

ACEA Therapeutics, Inc.

Conditions

Healthy VolunteersSystemic Lupus Erythematosus

Phase 1

Study of AC0058TA in Healthy Male and Female Subjects

CompletedNCT02847325

ACEA Therapeutics, Inc.Healthy Volunteers

Start: 2016-05-31End: 2017-04-30Updated: 2019-02-28

Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)

ACEA Therapeutics, Inc.Systemic Lupus Erythematosus

Start: 2018-11-28End: 2021-12-31Target: 32Updated: 2019-03-18